Developmental changes in iron metabolism and erythropoiesis in mice with human gain‐of‐function erythropoietin receptor

• Published in: American journal of hematology 2022-10, Vol.97 (10), p.1286-1299
• Main Authors: Kralova, Barbora, Sochorcova, Lucie, Song, Jihyun, Jahoda, Ondrej, Hlusickova Kapralova, Katarina, Prchal, Josef T., Divoky, Vladimir, Horvathova, Monika
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aging; Animals; Bone marrow; Erythrocytes; Erythropoiesis; Erythropoiesis - genetics; Erythropoietin; Erythropoietin - genetics; Erythropoietin - pharmacology; Fetuses; Gain of Function Mutation; Hematology; Hepcidin; Hepcidins - genetics; Hepcidins - metabolism; Heterozygotes; Homeostasis; Homozygotes; Hormones; Humans; Inflammation; Iron; Iron - metabolism; Iron deficiency; Life span; Mice; Nutrient deficiency; Polycythemia; Polycythemia - genetics; Receptors, Erythropoietin - genetics; Receptors, Erythropoietin - metabolism
• ISSN: 0361-8609; 1096-8652
• DOI: 10.1002/ajh.26658

Iron availability for erythropoiesis is controlled by the iron‐regulatory hormone hepcidin. Increased erythropoiesis negatively regulates hepcidin synthesis by erythroferrone (ERFE), a hormone produced by erythroid precursors in response to erythropoietin (EPO). The mechanisms coordinating erythropoietic activity with iron homeostasis in erythrocytosis with low EPO are not well defined as exemplified by dominantly inherited (heterozygous) gain‐of‐function mutation of human EPO receptor (mtHEPOR) with low EPO characterized by postnatal erythrocytosis. We previously created a mouse model of this mtHEPOR that develops fetal erythrocytosis with a transient perinatal amelioration of erythrocytosis and its reappearance at 3–6 weeks of age. Prenatally and perinatally, mtHEPOR heterozygous and homozygous mice (differing in erythrocytosis severity) had increased Erfe transcripts, reduced hepcidin, and iron deficiency. Epo was transiently normal in the prenatal life; then decreased at postnatal day 7, and remained reduced in adulthood. Postnatally, hepcidin increased in mtHEPOR heterozygotes and homozygotes, accompanied by low Erfe induction and iron accumulation. With aging, the old, especially mtHEPOR homozygotes had a decline of erythropoiesis, myeloid expansion, and local bone marrow inflammatory stress. In addition, mtHEPOR erythrocytes had a reduced lifespan. This, together with reduced iron demand for erythropoiesis, due to its age‐related attenuation, likely contributes to increased iron deposition in the aged mtHEPOR mice. In conclusion, the erythroid drive‐mediated inhibition of hepcidin production in mtHEPOR mice in the prenatal/perinatal period is postnatally abrogated by increasing iron stores promoting hepcidin synthesis. The differences observed in studied characteristics between mtHEPOR heterozygotes and homozygotes suggest dose‐dependent alterations of downstream EPOR stimulation.